Search results
Sep 29, 2009 · Genentech, a subsidiary of Roche, has purchased the Longa plant in Singapore to merge with its own biologics facility. Lonza Biologics Singapore has built a large-scale cell culture manufacturing facility in Singapore’s Tuas Biomedical Park.
On 31-Aug, Genentech Singapore – which is wholly-owned by Roche, has announced that it will buy Lonza manufacturing facility in Singapore at a purchase price of US$290 million plus additional milestone payments of US$70 million.
Aug 31, 2009 · Roche and Lonza announced today that Genentech Singapore Pte. Ltd. ("Genentech Singapore"), a wholly-owned member of the Roche Group, elected to exercise an option to purchase from Lonza its cell...
Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
In June 2007, Genentech began the construction and development of an E. coli manufacturing facility, also in Singapore, for the worldwide production of Lucentis (ranibizumab injection) bulk drug substance.
Mar 27, 2007 · Genentech is investing $140 million in Singapore to build a new biologics plant to manufacture the eye disease drug Lucentis. The deal marks another coup for Singapore, which just announced...
Oct 24, 2019 · In 2009, after we acquired a new manufacturing facility in Singapore, I was responsible for folding it into Genentech’s existing Singapore site. This included leading a team of 250 people and transitioning all aspects of the business, including technology systems, manufacturing systems, quality systems and financial processes, to name a few.
